Practice Research Report:
Multicenter evaluation of a new closed system drug-transfer device in reducing surface contamination by antineoplastic hazardous drugs
Sylvia B. Bartel, B.S. Pharm., M.P.H., Timothy G. Tyler, Pharm.D., FHOPA, FCSHP, Luci A. Power, B.S. Pharm., M.S.
American Journal of Health-System Pharmacy, Volume 75, Issue 4, 15 February 2018, Pages 199–211
To receive a copy of this Practice Research Report, please send your request here.
HALO® is a registered trademark of Corvida Medical, Inc.